Effect of Home-based Training Program for Kidney Transplant Recipients (HOMETRAIN-KTR)
Conditions: Kidney Transplant; Complications; Frailty; Physical Disability Interventions: Other: Training Sponsors: Oslo University Hospital; South-Eastern Norway Regional Health Authority Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
1 vs 7 RATG Infusions in Renal Transplantation
Conditions: Kidney Replacement Interventions: Drug: RATG; Drug: Basiliximab Sponsors: Mario Negri Institute for Pharmacological Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Transplant Wellness Program
Conditions: Transplantation Interventions: Behavioral: Transplant Wellness Program - Kidney and Liver Sponsors: University of Calgary Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations
Conditions: Delayed Graft Function; End Stage Renal Disease; Kidney Transplantation Interventions: Drug: Goal-Directed Fluid Therapy (GDFT); Drug: Regular Fluid Therapy Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
Conditions: Kidney Transplantation Interventions: Biological: TCD601; Drug: Tacrolimus (TAC); Drug: Corticosteroids (CS); Drug: Mycophenolate Mofetil (MMF); Drug: ATG Sponsors: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
GEnomic Medicine in Kidney Transplantation Study
Conditions: Transplant Complication; Kidney Transplant Rejection Interventions: Diagnostic Test: Biomarker discovery and validation - with focus on genomic biomarkers Sponsors: Western Sydney Local Health District Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Use of Wearables to Detect Infections in Kidney Transplant Recipients
Conditions: Kidney Transplant Infection Sponsors: Institute for Clinical and Experimental Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection
Conditions: Kidney Transplant Patients Eligible for a Solid Biopsy Sponsors: Assistance Publique - H ôpitaux de Paris; CGenetix; Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Tacrolimus Exposure in Kidney Transplantation
Conditions: Kidney Transplant Rejection Sponsors: Seoul National University Hospital; Astellas Pharma Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)
Conditions: Acute Kidney Injury Post Liver Transplantation Interventions: Drug: Arginine vasopressin; Drug: Norepinephrine Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Conditions: CMV Infection Interventions: Drug: Letermovir 480 MG; Drug: Ganciclovir Sponsors: Hospital do Rim e Hipertens ão Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Quantiferon CMV to Identify Treatment Need For Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
Conditions: Solid Organ Transplantation (Heart, Kidney, Lung, Liver); Cytomegalovirus Infections Interventions: Diagnostic Test: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes).; Other: Communication of the result of the QF-CMV to the clinician in charge Sponsors: University Hospital, Grenoble Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Molecular Landscape of Microvascular Inflammation in Kidney Allografts
Conditions: Kidney Rejection Transplant Interventions: Other: No intervention Sponsors: Paris Translational Research Center for Organ Transplantation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients
Conditions: Acute Kidney Injury; Chronic Kidney Diseases; Graft Failure Sponsors: Asan Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
Conditions: Bladder Disease; Bladder, Neurogenic; Bladder Cancer; Kidney Failure Interventions: Procedure: Bladder Transplantation; Procedure: Combined Kidney and Bladder Transplantation Sponsors: University of California, Los Angeles Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
